Hemophilia Foundation of Illinois – Trademark Portfolio
Entity Type: 99
Hemophilia Foundation of Illinois holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BLEEDING DISORDERS ALLIANCE ILLINOIS. The owner is based in Chicago, IL.
210 S. DesPlaines St.
Chicago, IL 606615500
Showing of trademarks Trademarks
Trademark Classifications
Hemophilia Foundation of Illinois's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Hemophilia Foundation of Illinois have?
Hemophilia Foundation of Illinois has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hemophilia Foundation of Illinois file in?
Hemophilia Foundation of Illinois files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Hemophilia Foundation of Illinois's most well-known trademarks?
Hemophilia Foundation of Illinois's registered trademark portfolio includes well-known marks such as BLEEDING DISORDERS ALLIANCE ILLINOIS. These are among 1 currently registered trademark in the portfolio.
What is Hemophilia Foundation of Illinois's trademark registration success rate?
Hemophilia Foundation of Illinois has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.